May 23, 2006
FDA Urges Stronger Warning for Ketek
Posted at May 23, 2006 8:10 AM in Drug Products
.
Citing a growing number of deaths related to liver failure, the FDA has called for a stronger warning label for the antibiotic drug KetekThe FDA has received reports of 12 cases of acute liver failure, including the four deaths, in patients treated with Ketek, according to a copy of an FDA memo. FDA safety evaluators also uncovered 23 other cases where patients suffered serious liver injuries after receiving the antibiotic, which is formally called telithromycin.
Trackback
You can ping this entry by using http://www.saundersblog.com/cgi-bin/mt/mt-tb.cgi/299 .